NCT05002595View on ClinicalTrials.gov

H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy

CompletedOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2021

Conditions
H. Pylori Infection
Interventions
DRUG

H. pylori eradication

Antimicrobial agents for H. pylori eradication

Trial Locations (1)

04401

Digestive Disease Center, Soonchunhyang University Hospital, Seoul

All Listed Sponsors
lead

Soonchunhyang University Hospital

OTHER

NCT05002595 - H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy | Biotech Hunter | Biotech Hunter